Literature DB >> 33531456

m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis.

Dongwen Rong1, Qian Dong2, Huajun Qu3, Xinna Deng4, Fei Gao4, Qingxia Li5, Ping Sun6.   

Abstract

Increasing evidence demonstrates that long noncoding RNAs (lncRNAs) play critical roles in human breast cancer (BC) tumorigenesis. However, the mechanisms by which lncRNA and N6-methyladenosine (m6A) regulate BC tumorigenesis are still unclear. In the present research, LINC00958 was markedly overexpressed in BC tissue and cells, and LINC00958 upregulation promoted the tumor progression of BC cells. Mechanistically, m6A methyltransferase-like 3 (METTL3) gave rise to the upregulation of LINC00958 by promoting its RNA transcript stability. Moreover, LINC00958 acted as a competitive endogenous RNA for miR-378a-3p to promote YY1. Overall, these data provide novel insight into how m6A-mediated LINC00958 regulates BC tumorigenesis.

Entities:  

Year:  2021        PMID: 33531456     DOI: 10.1038/s41420-020-00382-z

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  1 in total

1.  Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism.

Authors:  Tong Wang; Zhiyong Wang; Ruifang Niu; Liang Wang
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

  1 in total
  13 in total

1.  N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer.

Authors:  Rui Shi; Ziwei Wang; Jun Zhang; Zhicheng Yu; Lanfen An; Sitian Wei; Dilu Feng; Hongbo Wang
Journal:  Int J Gen Med       Date:  2021-11-16

Review 2.  The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.

Authors:  Lin Luo; Yingwei Zhen; Dazhao Peng; Cheng Wei; Xiaoyang Zhang; Xianzhi Liu; Lei Han; Zhenyu Zhang
Journal:  Cell Death Discov       Date:  2022-07-18

Review 3.  The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers.

Authors:  Lin Yao; Chang-Feng Man; Rong He; Lian He; Jia-Bin Huang; Shou-Yan Xiang; Zhe Dai; Xiao-Yan Wang; Yu Fan
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

4.  Comprehensive analysis of N6 -methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma.

Authors:  Hong-Xu Zhu; Wen-Jie Lu; Wei-Ping Zhu; Song Yu
Journal:  J Clin Lab Anal       Date:  2021-11-05       Impact factor: 2.352

5.  microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.

Authors:  Yaqin Li; Tao Zhou; Xianyi Cheng; Dezhi Li; Meng Zhao; Wei V Zheng
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  MYC/MAX-Activated LINC00958 Promotes Lung Adenocarcinoma by Oncogenic Transcriptional Reprogramming Through HOXA1 Activation.

Authors:  Tao Zhang; Fei Su; Yong-Bin Lu; Xiao-Ling Ling; Huan-Yu Dai; Tian-Ning Yang; Bin Zhang; Da Zhao; Xiao-Ming Hou
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

Review 7.  The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.

Authors:  Zhaolin Chen; Ying Hu; Le Jin; Fan Yang; Haiwen Ding; Lei Zhang; Lili Li; Tingting Pan
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 8.  Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications.

Authors:  Venkata Naga Srikanth Garikipati; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2021-05-11

Review 9.  The emerging role of RNA N6-methyladenosine methylation in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Jiuda Zhao; Xue Wang; Yiran Si; Peng Jin; Haili Qian; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-05-27

10.  Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer.

Authors:  Jinguo Zhang; Benjie Shan; Lin Lin; Jie Dong; Qingqing Sun; Qiong Zhou; Jian Chen; Xinghua Han
Journal:  Front Cell Dev Biol       Date:  2021-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.